U
Biome Grow Inc. BIO
CNSX
Recommendation
Prev Close
$0.005
Volume
--
Avg Vol (90D)
0
Market Cap
$403.03K
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
-$0.014
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Aurora Cannabis (ACB) Soars 6.2%: Is Further Upside Left in the Stock?
10/8/2025 - Zacks Investment Research
Bio-Rad Laboratories (BIO, $296.52) RSI Indicator left the overbought zone on October 07, 2025
10/8/2025 - Tickeron - Stocks
Bio-Rad Laboratories (BIO, $309.17) RSI Indicator left the overbought zone on October 06, 2025
10/7/2025 - Tickeron - Stocks
A Look at Bio-Rad Laboratories's Valuation Following Precision Medicine Push and New ddPCR Platform Launches
10/6/2025 - Simply Wall St
Bio-Rad Laboratories (BIO, $305.49) price may drop as it broke higher Bollinger Band on Oct 03, 2025
10/4/2025 - Tickeron - Stocks
Bio-Rad Laboratories (BIO, $294.24) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 2, 2025
10/3/2025 - Tickeron - Technical Analysis
Bio-Rad Laboratories (BIO, $297.95) price may drop as it broke higher Bollinger Band on Oct 01, 2025
10/2/2025 - Tickeron - Stocks
Comparing Global Wholehealth Partners (OTCMKTS:GWHP) & Bio-Rad Laboratories (NYSE:BIO)
9/30/2025 - Ticker Report
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
9/30/2025 - GuruFocus
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
9/30/2025 - Business Wire
Assenagon Asset Management S.A. Sells 2,366 Shares of Bio-Rad Laboratories, Inc. $BIO
9/29/2025 - MarketBeat
Bio-Rad Laboratories (BIO, $270.41) price exceeded its 50-day Moving Average on September 25, 2025
9/26/2025 - Tickeron - Stocks
What is Zacks Research's Forecast for BIO FY2026 Earnings?
9/23/2025 - MarketBeat
Assessing Bio-Rad Laboratories's Valuation Following Launch of New EZ-Check Salmonella Detection Kit
9/21/2025 - Simply Wall St
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up - Still a Buy?
9/20/2025 - MarketBeat
Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach
9/18/2025 - Yahoo! Finance: News
How the Launch of EZ-Check Salmonella Kit at Bio-Rad Laboratories (BIO) Has Changed Its Investment Story
9/17/2025 - Simply Wall St
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - Time to Sell?
9/14/2025 - MarketBeat
Amundi Increases Holdings in Bio-Rad Laboratories, Inc. $BIO
9/13/2025 - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Stock Position Lessened by Select Equity Group L.P.
9/9/2025 - MarketBeat
Petrus Trust Company LTA Grows Position in Bio-Rad Laboratories, Inc. $BIO
9/8/2025 - MarketBeat
Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
9/4/2025 - SeekingAlpha
Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
9/4/2025 - Seeking Alpha: Transcripts
America's billionaires are older than ever, with one in five already in their 80s or 90s as millennials await the Great Wealth Transfer
9/4/2025 - Fortune
Bio-Rad Laboratories (BIO, $290.71) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 2, 2025
9/3/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$536.20K
Net Income (TTM)
-$1.57M
Balance Sheet
Total Assets (Q)
$96.30K
Total Debt (Q)
$3.09M
Total Liabilities (Q)
$3.66M
Book Value Per Share (Q)
-$0.0317
Cash Flow
Cash from Operations (TTM)
-$227.70K
Cash from Investing (TTM)
$124.20K
Cash from Financing (TTM)
$14.00K
Net Change in Cash (TTM)
-$89.20K
Filings
Filing Date
Thursday, November 30, 2023
Period Date
Saturday, September 30, 2023
Next Filing
(est)
Price History
Loading...
Beta
0.00
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
0.00%
90-Day Total Return
0.00%
Year to Date Total Return
0.00%
1-Year Total Return
0.00%
2-Year Total Return
0.00%
3-Year Total Return
-75.00%
5-Year Total Return
-88.89%
52-week Low
Oct 07, 2025 - --
52-week High
Oct 07, 2025 - --
Valuation
Market Cap
$403.03K - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
-0.16
Dividends and Shares
Shares Outstanding
112.42
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biomegrow.com
Phone Number
416-875-8395
Address
480 University Avenue
Toronto, ON M5G 1V2
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada. more